Immune to Cancer: The CRI Blog
-
CICON16: The Future of Cancer Immunotherapy
CICON16 ended by focusing on emerging treatments and technologies in cancer immunotherapy.
-
CICON16: The Power of Combinations
Targeting tumors from multiple angles improves our odds of success.
-
CICON16: Bacteria and Cancer Immunity
New research shows that bacteria within us can influence both the development of cancer and the immune…
-
CICON16: Corrupted by Cancer
Day 2 of CICON16 explored strategies to overcome challenges within the tumor microenvironment.
-
CICON16: Beyond PD-1 and CTLA-4: The New Checkpoints
The latest advances in using new checkpoint drugs to target LAG-3, Nrp1, IL-35R, CD36, and mitochondrial metabolism.
-
CICON16: Cancer Antigens and the Development of Personalized Immunotherapy Approaches
Antigens are the key to effective vaccines and the immune system’s ability to target cancer cells.
-
CICON16: Translating Science Into Survival
This Sunday, we are proud to welcome the top international experts in immunology and immunotherapy to New…
-
Love Is On for $1 Million
Choose to love CRI in the second annual Revlon LOVE IS ON Million Dollar Challenge.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.